secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIMEDX GROUP, INC. (MDXG)
CIK:        0001376339
Form:       8-K
Filed at:   2026-07-29T20:08:19+00:00
Accession:  0001376339-26-000074
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiMedx Q2 net sales $64M (-35% YoY); to acquire Sanara MedTech for ~$350M
-------------------------------------------------------------------------

- Net sales $64M vs $99M YoY; net loss $15M vs net income $10M YoY.
- Surgical product sales +15% YoY; Wound sales -61% YoY due to Medicare changes.
- Acquiring Sanara MedTech (SMTI) for $35/share ($33 cash + 0.4735 MDXG shares); ~$350M enterprise value.
- Consideration represents 46% premium to Sanara's 30-day VWAP; expected close by year-end.
- Financing via cash on hand and $300M term loan from Hayfin; FY2026 net sales guidance reiterated at $260-290M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1376339/000137633926000074/0001376339-26-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1376339/000137633926000074/mdxg-20260729.htm
  HTML page:      https://secwatch.observer/filing/0001376339-26-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer